Indications
Therapeutic Asset Ratings
5,098 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Relugolix
Prostate Carcinoma
Baptist Health South Florida
P3
B
(61)
Retatrutide
Type 2 Diabetes Mellitus
Eli Lilly and Company
P3
B
(61)
Ribociclib
HER2 Positive Breast Carcinoma
Danish Breast Cancer Cooperative Group
P3
B
(61)
Romidepsin
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer Center
P3
B
(61)
Romidepsin
T-Cell Non-Hodgkin Lymphoma
Sichuan University
P3
B
(61)
Romidepsin
Angioimmunoblastic T-Cell Lymphoma
The Lymphoma Academic Research Organisation
P3
B
(61)
Rucaparib
Ovarian Cancer
pharmaand GmbH
P3
B
(61)
Rucaparib
Peritoneum Cancer
pharmaand GmbH
P3
B
(61)
Sacituzumab Tirumotecan
Non-Small Cell Lung Carcinoma
Hunan Province Tumor Hospital
P3
B
(61)
Seladelpar
Primary Biliary Cholangitis
Gilead Sciences
P3
B
(61)
Sigvotatug Vedotin
Non-Small Cell Lung Carcinoma
Pfizer
P3
B
(61)
Siponimod
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals
P3
B
(61)
Sorafenib
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
P3
B
(61)
Sorafenib
Pediatric Hepatocellular Carcinoma
Children's Oncology Group
P3
B
(61)
Surufatinib
Neuroendocrine Neoplasm
Shanghai Changzheng Hospital
P3
B
(61)
Tislelizumab
Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
P3
B
(61)
Tislelizumab
Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris
P3
B
(61)
Tislelizumab
Diffuse Large B-Cell Lymphoma
Ningbo No. 1 Hospital
P3
B
(61)
Tucidinostat
T-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Xiamen University
P3
B
(61)
ubt251
Obesity Disorder
The United Bio-Technology (Hengqin) Co., Ltd.
P3
B
(61)
Veliparib
Triple-Negative Breast Carcinoma
National Cancer Institute (NCI)
P3
B
(61)
Vesemnogene Lantuparvovec
Spinal Muscular Atrophy
Lantu Biopharma
P3
B
(61)
xy0206
Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication
Shijiazhuang Yiling Pharmaceutical Co. Ltd
P3
B
(61)
Zovaglutide
Obesity Disorder
Beijing QL Biopharmaceutical Co.,Ltd
P3
B
(61)
10-(1-methylpiperidin-4-ylidene)-5,10-dihydro-4H-benzo[5,6]cyclohepta[1,2-b]thiophen-4-one
Peripheral Neuropathy
Tanta University
P3
B
(60)
Showing 2601 to 2625 of 5,098 assets
Previous
Page 105 of 204
Next